SARAH HILL: Open Payments
NPI 1891157467 · BILOXI, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$329 in 20 payments from 12 companies in 2025. Trend: 2023 $514 · 2024 $437 · 2025 $329
Food & beverage: $329
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $99 |
| PFIZER INC. | 3 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $30 |
| Novo Nordisk Inc | 1 | $23 |
| COLOPLAST CORP | 1 | $22 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
Products named: VRAYLAR, UBRELVY, CAPLYTA, NURTEC ODT, Ozempic, Titan, SPRAVATO, ELIQUIS.
Industry payments across MS — which companies pay providers there.
